• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
1,3,5-Trimethylbenzene
Glutaric Anhydride
1-Bromo-3-Methylbutane
TaYaCn Drying Basic Zinc Carbonate XSG series flash evaporation rotary dryer
TaYaCn Drying 4A Zeolite XSG series flash evaporation rotary dryer
4-Hydroxycoumarin

TUL Degu and Liraglutide insulin compound preparation obtained clinical approval.

April 27, 2023

Tag:

TUL Degu and Liraglutide insulin compound preparation obtained clinical approval.

Previous:350 million project construction started, and the development potential of TUL was accelerated

Next:First in China! The weight management medicine of Smeglutide Injection of TUL was approved for clini

You may like
More>>

Paracetamol

Paracetamol
4-VINYLPHENYLBORONIC ACID

4-VINYLPHENYLBORONIC ACID
Food Grade Emulsifier Calcium Pyrophosphate 96% Putrity

Food Grade Emulsifier Calcium Pyrophosphate 96% Putrity
4-Morpholino piperidine

4-Morpholino piperidine
Sulfadimethoxine

Sulfadimethoxine
GH320BK Single lane sachet(back sealing )granule packing machine

GH320BK Single lane sachet(back sealing )granule packing machine
Liquid Preparation System

Liquid Preparation System
3-Amino-4-bromo-6-chloropyridazine

3-Amino-4-bromo-6-chloropyridazine
4-(4-butylcyclohexyl) cyclohexanone

4-(4-butylcyclohexyl) cyclohexanone
4-Chloro diphenyl sulfide

4-Chloro diphenyl sulfide

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service